- Home
- Companies
- Nirmidas Biotech, Inc.
- Products
- MidaSpot - COVID-19 Antibody Combo ...
MidaSpot - COVID-19 Antibody Combo Detection Kit
The MidaSpot COVID-19 Antibody Combo Detection Kit is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human serum, plasma (EDTA or lithium heparin), and capillary whole blood (POC fingerstick) . Nirmidas has obtained FDA EUA for this test.isting fluorescence based microplate readers.
Product Name: MidaSpot® COVID-19 Antibody Combo Detection Kit
Part Number: NBPC-0007
Package Unit: 25 Tests/Kit
1 Kit Contains:
-
25 Test Cards
-
1 Dropper Bottle of Sample Diluent
-
25 Safety Lancets
-
25 Non-Sterile Capillary Tubes
-
1 Instructions for Use
-
1 Quick Reference Guide
-
25 Sample Test Report Forms
Pricing
-
Larger volume discounts available
-
Contact us for your final price
Lead Time:
-
Small volumes up to 100 kits in stock and ready to ship immediately
-
Contact us for your lead time estimate
PRODUCT MANUFACTURED IN THE US
-
Nirmidas is an innovative US company in Palo Alto, CA (part of Stanford StartX COVID-19 task force)
-
Nirmidas developed and owns all IP related to the product.
-
Authorized by FDA EUA for the point-of-care fingerstick testing at CLIA and CLIA waiver sites
-
Nirmidas has a strong regulatory and quality compliance team
PRODUCT IS BOTH USER FRIENDLY AND ACCURATE AS A QUALITATIVE TEST
-
Went through multiple rigorous clinical studies and research studies and yielded excellent performance results
-
Independently evaluated by the National Cancer Institute
-
Identified as the top-performing test among 16 similar tests evaluated by a top university in the US
-
Clinical performance using fingerstick testing has nearly 100% sensitivity and specificity (see Instructions for Use for detailed performance data)
-
A uniquely designed capillary tube for precise and least invasive blood draw